With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved metreleptin, in combination with diet, for the treatment of complications of leptin ...

Lipodystrophy is a collective term used to describe a bunch of heterogeneous conditions associated with body fat and predisposition to metabolic illnesses such as ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve their ...

Aegerion Pharmaceuticals’ Myalepta, a treatment for the ultra-rare condition lipodystrophy, has been approved by the EC as an adjunct to diet as a replacement therapy to treat the complications of ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Acquired Lipodystrophy is a condition where the body abnormally stores or loses fat, typically beneath the skin. Unlike congenital forms, acquired types develop later in life. Acquired Lipodystrophy ...

"Lipodystrophy Syndrome Market Insight, Epidemiology and Market Forecast - 2032"The lipodystrophy syndrome market is experiencing significant expansion, driven by increasing disease awareness, rising ...

SEATTLE, March 17, 2021, (PHARMIWEB) — HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from ...